Views & Analysis | Perspectives on pharma industry issues

Digital

pharmaphorum podcast Episode 284, Mati Gill, AION Labs

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

R&D

Auto vacuum sealed vaccines in manufacturing plant

Reliability in life sciences logistics: What good looks like

What constitutes a reliable supply chain is changing rapidly.

Oncology

How AI is advancing patient subgroup identification in oncol...

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

Oncology

Personal reflections on World ADC, San Diego

At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.

Oncology

ESMO26: Taiho Oncology on improving the lives of patients wi...

Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.

Articles

Government plans to mobilise patient data – communicating he...

Following a recent discussion meeting held by IMS on Government plans to mobilise patient data, Rebecca Aris shares the topics discussed. The UK government announced this year that there will be a change to the NHS constitution to allow anonymised patient data to be made available for...

Articles

The evolution of medical education

pharmaphorum interviews leader in the CME industry, Maureen Doyle-Scharff of Pfizer. The past twenty years have seen significant change in the CME arena. We speak with CME Industry leader, Maureen Doyle-Scharff of...

Articles

Global pharma brands: are they worth the effort?

Ed Stapor of Havas Health questions whether global brands are worth the effort and highlights the success factors for achieving top pharma global brands. What do Apple, Coca-Cola, McDonald’s, BMW, HSBC, Nike, Disney, IKEA, Starbucks, and Louis Vuitton have in common? Each has clearly...

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

Digital

A sponsored video interview with Axria's Jeff Kaminski

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.